Shannon Briscoe
Human Resources Officer at ARBUTUS BIOPHARMA CORPORATION
Network origin in Shannon Briscoe first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Shannon Briscoe via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Founder Chief Executive Officer Chief Executive Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal President | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| UNILIFE CORP | Medical Specialties | Director of Finance/CFO Compliance Officer | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member President | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Chairman Director/Board Member | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Dyer Ellis & Joseph
 Dyer Ellis & Joseph Miscellaneous Commercial ServicesCommercial Services Part of Blank Rome LLP, Dyer Ellis & Joseph is a legal services provider. The company is based in Washington. Dyer Ellis & Joseph was acquired by Blank Rome Comisky & McCauley LLP on January 07, 2003. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| KRYSTAL BIOTECH, INC. | Biotechnology | General Counsel | |
Blank Rome LLP
 Blank Rome LLP Miscellaneous Commercial ServicesCommercial Services Blank Rome LLP provides legal services. The firm's services include commercial litigation, labor and employment benefits, bankruptcy, energy, financial services, health care, shareholder activism, tax and many more. The company was founded in 1946 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Koch Industries, Inc.
 Koch Industries, Inc. Oil Refining/MarketingEnergy Minerals Koch Industries, Inc. engages in the manufacture and trade of chemical products. It operates in variety of industries such as polymers and fibers, fertilizers, electronics, automotive components, forest and consumer products, minerals, glass, process and pollution control systems, refining and biofuels, commodity trading, investments, and ranching. The company was founded by Frederick Chase Koch in 1940 and is headquartered in Wichita, KS. | Oil Refining/Marketing | Corporate Officer/Principal | |
| Hampden-Sydney College | College/University | Undergraduate Degree | |
| Willamette University | College/University | Graduate Degree | |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of Metro Los Angeles is a non-profit organization that was founded in December 2015 to provide a sustainable solution to the opportunity crises facing vulnerable children in the neediest neighborhoods of Los Angeles. Boys & Girls Clubs of Metro Los Angeles is based in Los Angeles, CA, and has subsidiaries in the United States. The organization operates four clubs in Bell Gardens, Challengers, Downs, and Willowbrook, and offers nationally recognized, research-based programs and activities in three core areas: academic success, good character and citizenship, and healthy lifestyles. The organization empowers youth to explore a future with endless possibilities by offering creative programming, such as new approaches to science, technology, engineering, and math (STEM) created in collaboration with community partners. The non-profit company was founded in 2015, and the CEO is Patrick Mahoney. | Miscellaneous Commercial Services | Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Director/Board Member | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| UNC School of Medicine | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| EARGO, INC. | Medical Specialties | Director/Board Member | |
Novast Pharmaceuticals Ltd.
 Novast Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Novast Holdings Ltd., Novast Pharmaceuticals Ltd. develops and distributes pharmaceutical drugs. The company is based in Nantong, China. | Pharmaceuticals: Major | Director/Board Member | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Chairman | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
Point32health Services, Inc.
 Point32health Services, Inc. Life/Health InsuranceFinance Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA. | Life/Health Insurance | Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chairman | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Respivant Sciences, Inc.
 Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Respivant Sciences, Inc. is a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases. The company is based in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
Unilife Medical Solutions, Inc.
 Unilife Medical Solutions, Inc. Electronic Equipment/InstrumentsElectronic Technology Unilife Medical Solutions, Inc. operates as a medical device contract manufacturer of disposable devices. It engages in the design, development, and validation of automated equipment used in the production of medical devices. The firm’s project management services include product design and support and prototyping, molding, assembly, printing, packaging, sterilization, and quality control. The company is headquartered in York, PA. | Electronic Equipment/Instruments | Compliance Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Willamette University College of Law | College/University | Graduate Degree | |
| Rice University | College/University | Doctorate Degree |
Statistics
International
| United States | 41 |
| United Kingdom | 5 |
| Bermuda | 3 |
| Ireland | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 4 |
| Energy Minerals | 2 |
Operational
| Director/Board Member | 84 |
| Corporate Officer/Principal | 41 |
| Independent Dir/Board Member | 26 |
| Chairman | 17 |
| Undergraduate Degree | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Frank Torti | 35 |
| Daniel Burgess | 28 |
| Richard Henriques | 15 |
| Keith Manchester | 15 |
| John Naftzger | 12 |
| David Hastings | 12 |
| Eric Venker | 12 |
| Michael Sofia | 10 |
| Andrew Cheng | 10 |
| James Meyers | 9 |
| Lisa M. Caperelli | 9 |
| William Collier | 8 |
| Michael McElhaugh | 7 |
| Melissa Rewolinski | 7 |
| Elizabeth Howard | 6 |
- Stock Market
- Insiders
- Shannon Briscoe
- Company connections
